The QualityStocks Daily Stock List
- Almonty Industries, Inc. (ALMTF)
- Arista Financial Corp. (ARST)
- BioCardia, Inc. (BCDA)
- Draganfly, Inc. (DFLYF)
- eMARINE Global, Inc. (EMRN)
- Fearless Films, Inc. (FERL)
- Xebec Adsorption, Inc. (XEBEF)
- MGX Minerals, Inc. (MGXMF)
- Almost Never Films, Inc. (HLWD)
- Blue Line Protection Group, Inc. (BLPG)
- MMEX Resources Corp. (MMEX)
- Lexington Biosciences, Inc. (LXGTF)
- Maricann Group, Inc. (MRRCF)
- Purebase Corp. (PUBC)
Almonty Industries, Inc. (ALMTF)
Penny Stock Hub, Mining News Feed, Silicon Investor, 4-Traders, Junior Mining Network, OTC Markets, Morningstar, wallstreet online, Financial Buzz, Stockwatch, Seeking Alpha, InvestorsHub, Nasdaq, Wallet Investor, otc.watch, and Stockhouse reported earlier on Almonty Industries, Inc. (ALMTF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Almonty Industries, Inc. focuses on the mining, processing, and shipping of tungsten concentrate from its Los Santos mine in western Spain and its Panasqueira mine in Portugal. The Company also focuses on the development of its Sangdong tungsten mine in Gangwon Province, South Korea, and the development of the Valtreixal tin/tungsten project in northwestern Spain. Almonty Industries has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQX.
In September of 2011, the Los Santos mine was acquired by Almonty Industries. It is positioned roughly 50 kilometers from Salamanca in western Spain and produces tungsten concentrate.
The Panasqueira mine has been in production since 1896. It is situated roughly 260 kilometers northeast of Lisbon, Portugal. It was acquired in January of 2016 and produces tungsten concentrate.
In September 2015, the Sangdong mine was acquired via the acquisition of a 100 percent interest in Woulfe Mining Corp. Almonty Industries owns 100 percent of the Valtreixal tin-tungsten project in northwestern Spain.
In May of 2019, Almonty Industries announced that it signed a Power Supply and Consumption Agreement with Korea Electric Power Corporation (KEPCO) for the construction and supply of a power line to the Sangdong Tungsten Mine situated in the Republic of Korea. The Power Supply and Consumption Agreement, entered into on May 29, 2019 between Almonty Korea Tungsten Corp. (AKTC), a wholly-owned subsidiary of Almonty Industries, and KEPCO, a state-owned monopoly power supplier, is for the construction and installation of a 10MW exclusive power line to the site of the Sangdong Mine. Under the Power Supply & Consumption Agreement, KEPCO is responsible for constructing the high voltage power line (22.9kV) of 22.8 km and auxiliary facilities connecting the Taebaek Sub-station of KEPCO and the transfer point designated inside the Sangdong Mine site.
In November 2019, Almonty Industries announced a non-brokered private placement raising gross proceeds of up to $1,300,000 via the issuance of up to 2,047,244 units at a price of $0.635 per unit. Proceeds from the private placement will be used to finance the closing costs of the Sangdong Project Financing and for general working capital.
Almonty Industries, Inc. (ALMTF), closed Friday's trading session at $0.3346, up 3.2716%, on 8,914,705 volume with 9 trades. The average volume for the last 3 months is 10,723 and the stock's 52-week low/high is $0.286403/$0.805050015.
Arista Financial Corp. (ARST)
Wallet Investor, OTC Markets, Newsfilter.io, Stockhouse, Market Exclusive, Investors Hangout, InvestorsHub, Simply Wall St, Morningstar, Dividend Investor, TradingView, and Seeking Alpha reported earlier on Arista Financial Corp. (ARST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Arista Financial Corp. is a financial service holding company. It seeks to take advantage of the present vehicle finance marketplace by way of its wholly-owned subsidiary, Arista Capital. The Company provides innovative financing options to small lenders. It acts as a funding source to finance the lending activities of other asset-based lenders who are in need of considerable capital to grow their lending base. Arista Financial has its head office in Short Hills, New Jersey. The Company lists on the OTC Markets.
Arista Financial participates in the above-mentioned market via an array of funding arrangements. This includes debt financings, loan purchases or direct loan participations. The Company’s belief is that although small asset based lenders have limited access to capital after the financial crisis required to enable growth, these lenders have a very well managed and maintained origination, underwriting and administrative infrastructure. These lenders also have substantial expertise and experience in their specific area of lending.
Arista has accessed this experience and infrastructure by participating with these lenders in their lending opportunities. Therefore, it provides these small lenders with an ability to make additional loans that they otherwise would not be able to do either directly through a loan participation program with Arista or indirectly by allowing Arista to make the loan that they administer and hence better use their infrastructure.
Arista Financial seeks to partner with other experienced lending companies to make or buy equipment based loans where the collateral can be readily valued and easily repossessed if necessary and the rates are appropriate for the risk. The Company has seen this opportunity in the transportation equipment area. It has started to make and purchase transportation equipment loans (i.e. trucks). In addition, it will look at additional market areas if they have the same economics.
Arista Financial provides Financing options to equipment leasing companies to grow their portfolios. Regarding Portfolio Acquisitions, it acquires lease portfolios from the leasing companies and it continues to service those leases. Concerning Portfolio Growth Funding, this structure has allowed Arista’s partners to increase their own portfolio because of their ability to respond quickly and fund the transaction. Pertaining to a Line of Credit, having a line of credit allows leasing companies to bridge gaps in their present ability to self-fund transactions.
This past June, Arista Financial announced that it intends to enter the mortgage industry. The Company is expanding its lending capabilities to include mortgage products and services. It has already commenced the process of conducting extensive due diligence on a number of potential acquisition opportunities in the mortgage lending industry especially related to entities that have experience or the capability to do reverse mortgages.
Moreover in October 2019, Arista Financial announced that it will enter the mobility industry. It intends to carry out its activities in the mobility industry directly and also through a newly created majority-owned subsidiary, Arista Mobility Group Ltd.
Arista Financial Corp. (ARST), closed Friday's trading session at $0.0012, off by 7.6923%, on 28,000,210 volume with 66 trades. The average volume for the last 3 months is 15,111,242 and the stock's 52-week low/high is $0.001/$1.48000001.
BioCardia, Inc. (BCDA)
Zacks, TipRanks, Morningstar, last10k, Stock Twits, Stockwatch, Insider Tracking, Street Insider, Stockopedia, AI Stock Finder, Stockhouse, Marketplace.org, MarketBeat, Proactive Investors, Capital Cube, Wallet Investor, Dividend Investor, Barchart, and GuruFocus reported earlier on BioCardia, Inc. (BCDA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
BioCardia, Inc. is a leader in the development of comprehensive solutions for cardiovascular regenerative therapies. The Company’s biotherapeutic product candidates in clinical development are CardiAMP and CardiALLO cell therapies. Furthermore, BioCardia partners with other biotherapeutic companies. This is to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, as well as acute myocardial infarction. A clinical-stage regenerative medicine company, BioCardia is based in San Carlos, California. The Company lists on the NasdaqCM.
Additionally, BioCardia offers the Helix biotherapeutic delivery system; and the Morph vascular access product line, which provides catheter products. The Company’s lead therapeutic candidate is the investigational CardiAMP™ Cell Therapy System. This System provides an autologous bone marrow derived cell therapy (using a patient's own cells) for the treatment of two clinical indications. These are heart failure that develops after a heart attack and chronic myocardial ischemia.
BioCardia’s second therapeutic candidate is the investigational CardiALLO™ Cell Therapy System. This is an allogeneic culture expanded "off the shelf" cell therapy derived from donor bone marrow cells, which have been identified to meet specified criteria. The therapy has the potential to be advanced for manifold clinical indications, including heart failure.
In October 2019, BioCardia announced renewal of the CE Mark for the Helix™ Biotherapeutic Delivery Catheter and Morph® Universal Deflectable Guide Catheter, both used in the delivery of biotherapeutics to the heart. CE Mark renewal allows the Company to continue supporting partners conducting biotherapeutic clinical trials outside of the United States, such as CellProThera and Centro Cardiologico Monzino, and also commercial sales in the European Union (EU) and other countries that recognize the CE Mark through May 2024.
Recently, BioCardia reported financial results and business highlights for Q3 2019 and filed its quarterly report on Form 10-Q for the three and nine months ended September 30, 2019 with the Securities and Exchange Commission (SEC). BioCardia recently received FDA (Food and Drug Administration) approval for an IDE supplement for the Phase III pivotal CardiAMP Heart Failure Trial of its lead therapeutic candidate. This will permit patients in the control group to cross over to CardiAMP treatment once their follow-up for the CardiAMP Trial has finished.
For Q3 2019, Revenue was $194,000. This represents an increase of $110,000 from Q3 of 2018. Net Loss was $3.8 million for Q3 of 2019, versus a $3.5 million Net Loss for Q3 of 2018.
BioCardia, Inc. (BCDA), closed Friday's trading session at $4.00, up 2.4643%, on 32,743 volume with 305 trades. The average volume for the last 3 months is 12,304 and the stock's 52-week low/high is $3.47000002/$5.09000015.
Draganfly, Inc. (DFLYF)
OTC Markets, Penny Stock Hub, TeleTrader, Wallet Investor, Stockhouse, and Dividend Investor reported earlier on Draganfly, Inc. (DFLYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Draganfly, Inc. is an award-winning, industry-leading manufacturer within the commercial UAV (unmanned aerial vehicles) and UVS (unmanned vehicle systems) space. The Company serves the public safety, agriculture, industrial inspections, and mapping and surveying markets. Incorporated in 1998, Draganfly has its corporate headquarters in Saskatoon, Saskatchewan. It also has an office in Los Angeles, California. The Company’s shares trade on the OTC Markets Group’s OTCQB.
Draganfly is the creator of quality, pioneering, UVS and software that revolutionizes the way people do business. The Company has recognition as being at the vanguard of technology for more than 21 years. Draganfly is considered the oldest commercial drone company in the world.
Draganfly Innovations is a subsidiary of Draganfly. Draganfly Innovations is an award-winning, industry-leading manufacturer within the commercial Remotely Piloted Aircraft System (RPAS) and the UVS space.
The Company’s products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and sensors, and also software used for tracking, live streaming, and data collection. In addition, Draganfly offers consulting services, including custom engineering and training, and simulation consulting, as well as flight training services.
In December, Draganfly subsidiary, Draganfly Innovations announced that it has been registered with the Controlled Goods Program of Canada. “Controlled goods” is a term used to refer to equipment used in Canada’s defense and security industries. This includes, but is not limited to, military equipment, communications equipment, and related pieces of intellectual property (IP).
With this registration, Draganfly is authorized to work with and handle ITAR (International Traffic in Arms Regulations) controlled goods and technologies. The registration simplifies the regulatory process United States clients face when contracting Draganfly for sensitive projects.
Draganfly states that the inclusion of ITAR compliant practices through the Controlled Goods Program is an indicator of the Company’s commitment to serving customers with quality and regulatory excellence. This means that the required controls are in place to ensure that all controlled data and products are only available to approved personnel. The process assures government and military customers that these materials will not get into the hands of non-authorized persons.
Draganfly, Inc. (DFLYF), closed Friday's trading session at $0.48, up 0.041684%, on 500 volume with 1 trade. The average volume for the last 3 months is 4,510 and the stock's 52-week low/high is $0.446299999/$1.46000003.
eMARINE Global, Inc. (EMRN)
TipRanks, Financial Buzz, Stock Pulse, TeleTrader, Global Banking and Finance, Wallmine, Market Wire News, TradingView, Street Insider, GuruFocus, Corporate Information, Wallet Investor, Stockhouse, Market Screener, InvestorsHub, Morningstar, Stockopedia, Nasdaq, GlobeNewswire, Stockwatch, Simply Wall St, and last10k reported beforehand on eMARINE Global, Inc. (EMRN), and today we report on the Company, here at the QualityStocks Daily Newsletter.
eMARINE Global, Inc. is a leading provider of information and communications technology (ICT) for the maritime industry. The Company provides solutions for the collection, integration and display of maritime information abroad and ashore through electronic means to enhance berth to berth navigation and related services. The Company formerly went by the name Pollex, Inc. It changed its name to eMarine Global, Inc. in August of 2017. Incorporated in 2001, eMARINE Global has offices in Ulsan and Seoul, South Korea.
eMARINE Global is working with a growing base of marquee customers to achieve maritime ICT convergence via fully integrated products and services. The Company provides state-of-the-art e-navigation, marine Internet of Things (IoT), and marine big data solutions, primarily in Korea with near-term expansion into United States and Chinese markets.
eMARINE Global’s solutions provide the most efficient means to secure the safety of life at sea and to protect the marine environment. All products and services are provided by way of subscription, installation, updates and/or maintenance contracts.
The Company offers electronic chart display and information systems (ECDIS), a computer-based navigation system; and electronic navigation charts (ENC), which integrates position information from the global positioning system (GPS) and other navigational sensors, including radar, fathometer, and automatic identification systems.
eMARINE Global also provides smart ship solutions, including intra-ship integrated gateway (ISIG), an intra-ship network; collision avoidance and optimal voyage systems; and remote maintenance and engine monitoring systems. The Company engages in the distribution of overseas solutions, such as CARIS, a maritime GIS software; digital charts; and Hatteland, a maritime-specialized hardware. It also provides Aids to Navigation (AtoN) management systems consisting of maritime weather signals total management system, and e-A2N device.
eMARINE Global generated 56 percent year-over-year Revenue growth in Q3 ended September 30, 2019. The $1.4 million Revenue reported for the quarter was driven chiefly through a special promotion related to sales of Teledyne CARIS technology. eMARINE Global is the exclusive distributor of Teledyne CARIS products in South Korea. Net Income for the three months ended September 30, 2019 rose 394 percent year-over-year to $532,000, propelled by increased sales of higher-margin products and reduced related SG&A expenses.
Recently, eMARINE Global announced that it signed a contract with Hanjin Heavy Industry & Construction Co., Ltd (HHIC) to supply the Company’s e-Navigator system for four new build Republic of Korea Navy (ROKN) ships. The contract is valued at an estimated 100 million won (US$0.85 million).
e-Navigator is eMARINE Global’s core brand of warship Electronic Chart Display & Information System (ECDIS). At present, the Company provides continuing maintenance of its warship ECDIS technology on 215 ROKN vessels on an annually contracted basis.
eMARINE Global, Inc. (EMRN), closed Friday's trading session at $0.30, even for the day, on 201 volume. The average volume for the last 3 months is 1,182 and the stock's 52-week low/high is $0.1717/$4.00.
Fearless Films, Inc. (FERL)
StockPrice, PennyStockBase, TipRanks, Stock Target Advisor, Simply Wall St, OTC Markets, Investors Observer, Stockhouse, Dividend Investor, Dividend.com, Nasdaq, Stockwatch, InvestorsHub, Stockopedia, last10k, TradingView, Wallet Investor, and PR Newswire reported beforehand on Fearless Films, Inc. (FERL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Fearless Films, Inc. engages in the video and film production and distribution business. It is an independent full-service production company founded by award-winning actor, producer Mr. Victor Altomare. The Company produces first-rate entertainment with an edge. The service scope specializes in short film and feature film production in addition to script writing, copywriting, fulfillment and distribution. Fearless Films is headquartered in Concord, Ontario.
The Company has, since its inception, been on the map as a leading independent producer winning accolades at most major film festivals. Fearless Films has recognition for having a keen eye for emerging talent.
Fearless Films’ services include production elements, such as creative brief, editing, script writing, talent acquisition, voice overs, sound tracks, and graphical animation. It provides its services to directors and writers, and also for post-production and distribution/fulfillment.
At the end of October 2019, Fearless Films announced that it furthered discussions around its intent to acquire the rights to up to 12 movies from a library held by Mr. Victor Altomare, the President of Fearless Films, Inc., the Company's operating subsidiary. The Company chose The Lunatic as the first film to be selected for appraisal and final negotiation.
The Lunatic premiered at the Montreal Film festival, won the bronze award in Houston and won the Gold award at the Yorkton, Saskatchewan festival. The movie starred Victor Altomare, Lazar, Jennifer Dale, as well as boxing great George Chuvalo. It was produced by Victor Altomare and directed by Robert Longo.
In December, Fearless Films, Inc. announced that it entered in a $5 million equity financing facility with Crown Bridge Partners, LLC. These funds will be used to develop the Company's film assets by providing capital to complete film projects and to enable Fearless Films to participate as a partner with other production firms. In addition, this facility will be used to provide capital for general corporate purposes.
Fearless Films, Inc. (FERL), closed Friday's trading session at $0.111, off by 11.2%, on 13,568 volume with 3 trades. The average volume for the last 3 months is 20,503 and the stock's 52-week low/high is $0.111000001/$3.27999997.
Xebec Adsorption, Inc. (XEBEF)
Hot Stocks Review, Market Seat, Street Insider, Proactive Investors, OTC Markets, Investor Ideas, Midas Letter, Wallet Investor, Investors Hangout, Market Screener, Morningstar, Stockhouse, Barchart, Nasdaq, TradingView, PR Newswire, Canadian Insider, Seeking Alpha, Stockwatch, GlobeNewswire, MarketWatch, and Macroaxis reported beforehand on Xebec Adsorption, Inc. (XEBEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Xebec Adsorption, Inc. is an international provider of clean energy solutions. The Company provides gas generation, purification and filtration solutions for the industrial, energy and renewables marketplace. It has proprietary technologies that transform raw gases into clean sources of renewable energy. Xebec Adsorption’s customers range from small to multi-national corporations, governments and municipalities looking to reduce their carbon footprints. Xebec Adsorption is based in Blainville, Quebec. In addition, the OTCQX-listed Company has several Sales and Support offices in North America and Europe, as well as two manufacturing facilities in Montréal and Shanghai.
Xebec Adsorption’s head office in Blainville, Quebec is a 41,753 square foot manufacturing facility. The Blainville operation houses corporate finance, sales and application support, filtration and aftermarket, global supply chain, operational engineering, manufacturing and service and maintenance support.
The Company’s Asian 20,451 square foot manufacturing facility is in the Song Jiang district of Shanghai, China. This facility is responsible for sales, product engineering and assembly using components manufactured in the greater Shanghai industrial area. Furthermore, this facility provides shared services. This includes supply chain and engineering support to Xebec’s head office. Moreover, Xebec Shanghai is responsible for sales of Xebec’s products, marketing, technical and after-sales support for the Asian and South East Asian markets.
Xebec Adsorption designs, develops, builds, sells, and services a range of pressure swing adsorption and membrane gas purification systems for biogas purification (BGX Solutions™); natural gas dehydration and conditioning units for natural gas vehicle refueling stations and for natural gas upgrading (NGX Solutions™); hydrogen purification pressure swing adsorption (PSA) systems (H2X Solutions™); helium purification systems (SGX Solutions™); field gas or associated gas purification systems (AGX Solutions™); and filtration and separation equipment (FSX Solutions™).
In December, Xebec Adsorption announced that Xebec Holding USA, Inc, a wholly-owned subsidiary of the Company entered into an agreement and effective December 10, 2019, to acquire through a cash purchase all of the outstanding securities of CDA Systems. CDA’s principals will remain with CDA after the acquisition to optimize their integration into Xebec Adsorption’s industrial service and increase the business over the coming years.
CDA Systems is a foremost distributor and service provider of Oil-Free Air Compressors, Air Dryers, and Filtration Systems in California’s San Francisco Bay Area. CDA designs, sells, rents, as well as maintains Clean Dry Air systems. Moreover, Xebec has signed a Letter of Intent (LOI) with Maas Energy Works to provide four small-scale, containerized biogas upgrading units in California. These Biostream™ units will support the production of renewable natural gas from biogas streams generated from animal waste on small dairy farms situated throughout California.
Xebec Adsorption, Inc. (XEBEF), closed Friday's trading session at $1.9098, up 7.2921%, on 59,326 volume with 35 trades. The average volume for the last 3 months is 11,746 and the stock's 52-week low/high is $0.51999998/$2.00.
MGX Minerals, Inc. (MGXMF)
Proactive Investors, Wall Street PR, InvestorsHub, Wallet Investor, Dividend Investor, Stockhouse, OTC Markets, MarketWatch, 4-Traders, Morningstar, Capital Equity Review, The Street, Stockwatch, Equities, StockInvest.us, The Streetwise Reports, Barchart, and Market Screener reported previously on MGX Minerals, Inc. (MGXMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MGX Minerals, Inc. is a diversified resource company with its corporate headquarters in Vancouver, British Columbia. It centers on the development of large-scale industrial mineral portfolios in specific commodities and jurisdictions that will fuel the new energy economy. MGX Minerals controls considerable interest in lithium, magnesium and silicon assets throughout North America. The Company lists on the OTC Markets Group’s OTCQB.
MGX Minerals’ strategy is to identify commodities and jurisdictions where large-scale development opportunities exist. Additionally, the Company’s strategy is to build its asset portfolio via aggressive acquisition to quickly build and enhance long-term portfolio value. Furthermore, its strategy is to engage industry experts to lessen execution risk and quickly increase time to market.
The Company has regional control in most of the industrial mineral projects in the jurisdictions it operates. Pertaining to near-term potential, MGX Minerals concentrates on assets that offer streamlined development timelines and low initial capital expenditures (capex). It has developed a proprietary, low-energy design process (Rapid Recovery Process) that is patent-pending. The design of it is specifically for highly-mineralized brine associated with oilfields. The process quickly concentrates lithium and other minerals in brine.
MGX Minerals has completed pilot plant testing in South America on brine samples originating from numerous salars in Chile. The Company entered into a joint brine testing agreement with several South American mining companies. The parties are working to identify potential joint-venture (JV) locations that will utilize MGX Minerals’ lithium extraction technology.
Recently, MGX Minerals and engineering partner PurLucid Treatment Solutions reported that a second deployment of an advanced wastewater treatment system is near completion and commissioning is anticipated soon. This system is capable of processing up to 10m3 per hour. The system will substantially decrease greenhouse gases through energy savings on steam generation. The technology provides superior treatment outcomes versus conventional technology that requires offsite trucking and high cost (because of toxicity) disposal. PurLucid Treatment Solutions’ exclusively licensed and patented nanoflotation technology was designed purposely for oilfield environments.
MGX Minerals also recently reported that its collaborative research partnership with the University of British Columbia (UBC) completed a wide-ranging baseline assessment of metallurgical silicon originating from each of MGX’s three silicon projects in southeastern British Columbia. The Company and UBC are working together to develop next-generation Li-ion batteries capable of quadrupling energy density from present 100 Wh/kg up to 400 Wh/kg for use in long-range electric vehicles and grid storage.
MGX Minerals, Inc. (MGXMF), closed Friday's trading session at $0.06, up 54.2416%, on 210,875 volume with 50 trades. The average volume for the last 3 months is 152,444 and the stock's 52-week low/high is $0.028/$0.351900011.
Almost Never Films, Inc. (HLWD)
Street Insider, InvestorsHub, PR Newswire, Ticker Report, Penny Stock Hub, OTC Markets, The Street, YCharts, Barchart, Simply Wall St, Dividend Investor, Street Insider, Market Exclusive, MarketWatch, Marketbeat, and Equity Clock reported beforehand on Almost Never Films, Inc. (HLWD), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Almost Never Films, Inc. is an independent film company headquartered in Los Angeles, California. The Company’s emphasis is on film production, finance and production related services for movies under budgets of $35 million. Its business is to enable relationships between creative talent and companies who produce, finance and distribute motion pictures. Almost Never Films’ shares trade on the OTC Markets.
Almost Never Films’ goal is to create, acquire, or license rights to materials upon which it believes motion pictures can be based (screenplays, books, short stories, etc.). The Company has a strategic partnership with Pure Flix Entertainment. This partnership is a multi-film financing agreement to produce six faith-based original motion pictures.
Pure Flix Entertainment is a U.S. independent Christian film and television studio, based in Scottsdale, Arizona. Pure Flix Entertainment will distribute the films globally in new media format. Almost Never Films will contribute its financial, development, and production services.
Almost Never Films previously announced the release of its two faith-based films "The Prayer Box" and "Christmas Manger" (formerly named "Bethlehem Ranch") by Universal Pictures Home Entertainment, the home video distribution division of Universal Pictures. The launch of these two films marks the completion of the first two films of a multi-film financing agreement between Almost Never Films and Pure Flix Entertainment.
Recently, Almost Never Films announced that ION Television acquired the Company's holiday feature "Country Christmas Album". The network aired the film during 2018's holiday season. ION Television is a foremost family-oriented entertainment network. ION Television is a top 10-ranked U.S. general entertainment network. It is the flagship of the independent, privately held media company, ION Media. ION Media's 70 full-power stations reach 102 million homes.
The people behind Almost Never Films are originally from the finance industry. The Company is made up of private equity and investment professionals that have a passion for motion pictures.
Almost Never Films, Inc. (HLWD), closed Friday's trading session at $0.75, up 275.00%, on 101 volume with 2 trades. The average volume for the last 3 months is 652 and the stock's 52-week low/high is $0.200000002/$2.50999999.
Blue Line Protection Group, Inc. (BLPG)
Penny Stock Tweets, Stockwolf, Marketwired, YCharts, Capital Cube, Awesome Penny Stocks, Barchart, New Cannabis Ventures, Marijuana Stocks, Cannabiznetwork, and Dividend Investor reported earlier on Blue Line Protection Group, Inc. (BLPG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Blue Line Protection Group, Inc. provides consulting, armed security, compliance and investigations, transportation, and secure vaulting services to banks, businesses and government entities. The Company’s professional team consists chiefly of former military and law enforcement personnel with decades of experience in protection, investigations, logistics, and tactical industries. Blue Line Protection Group is based in Denver, Colorado and lists on the OTC Markets.
The Company works side-by-side with retail establishments. It lessens the risk of criminal activity and creates a secure retail experience through protecting businesses on-site and securing their assets on the road.
Blue Line helps retailers remain compliant with all applicable laws. Furthermore, it shows retail establishments how to protect their businesses through letting Blue Line assume the responsibility and liability for their protective services.
The Company serves banks and credit unions through providing currency processing and transportation solutions. Its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates. Blue Line Protection Group announced in October of 2018 that its Cash In Transit (CIT) operations, including vaulting, processing, and tactical compliance, is now available in Arizona.
Blue Line acts on behalf of banks and credit unions through collecting cash sales revenue from their client locations. Upon collecting the currency, the Company transports it to one of its secure processing facilities. Blue Line provides currency handling and validation services for the bank and transportation of processed currency to the Federal Reserve.
Blue Line Protection Group and Hypur have plans to open a cash vaulting and processing facility. This is to serve marijuana-related businesses (MRBs) and cash-intensive businesses (CIBs) in Nevada. Blue Line plans to partner with Hypur to expand services to Arizona, Oregon, Washington, California and Nevada. Hypur is a financial technology company based in Scottsdale, Arizona. The new Nevada facility will implement “Hypur Vault” cash management technologies.
Blue Line Protection Group’s Professional Affiliations include National Cannabis Industry Association, ASIS International, Marijuana Industry Group, Society of Corporate Compliance and Ethics, and Marijuana Business Association. Its Professional Affiliations also include International Association of Chiefs of Police, Professional Private Investigators Assn of Colorado, and Society for Human Resources Management.
Blue Line Protection Group, Inc. (BLPG), closed Friday's trading session at $0.0012, up 200.00%, on 241,456,888 volume with 634 trades. The average volume for the last 3 months is 4,188,312 and the stock's 52-week low/high is $0.0003/$0.003299999.
MMEX Resources Corp. (MMEX)
Discovery Stocks, HydroCarbonProcessing, Investors Hangout, MarketWatch, MicroCapDaily, Stockhouse, Business Wire, 4-Traders, InvestorsHub, Morningstar, OTC Markets, and Wallet Investor reported earlier on MMEX Resources Corp. (MMEX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MMEX Resources Corp. focuses on the acquisition, development and financing of oil, gas, refining and infrastructure projects in Texas and South America. The Company established to engage in the exploration, extraction, refining and distribution of oil, gas, petroleum products and electric power. A development-stage company, MMEX Resources is headquartered in Fort Stockton, Texas.
MMEX’s main areas of interest include the acquisition and potential development of refining, oil & gas assets in Texas, and the acquisition of oil and gas properties in Peru. In addition, main areas of interest include crude, oil and product export opportunities in Latin America, and the development of terminals, storage, refining, oil & gas in Brazil.
The Company’s projects include the Pecos County Refinery Project, Fort Stockton, Texas. Phase 1 of this project is a 10,000 BPD Crude Distillation Unit. Phase 2 is a 100,000 BPD Large-Scale Refinery. The project is in Sulfur Junction, about 20 miles northeast of Fort Stockton. The project is strategically positioned close to oil production in West Texas, with storage capability.
MMEX Resources signed an off-take agreement with Pilot Thomas Logistics. The off-take agreement is for the sale of its diesel fuel production from Phase 1 of the MMEX refinery project in Pecos County. In November 2017, MMEX Resources broke ground on Phase 1 of the MMEX Refinery Project in Pecos County. The agreement provides for Pilot Thomas Logistics to obtain 100 percent of the diesel production from Phase 1, roughly 4,200 barrels per day, for markets in the Permian Basin area principally for use in drilling operations.
MMEX Resources intends to develop a solar power project to provide electric power to its planned 10,000 barrel-per-day (BPD) crude distillation unit and its full-scale crude oil refinery in Pecos County near Fort Stockton, Texas.
In October 2018, MMEX Resources and Blanchard Industrial, LLC (BIL) announced that BIL will be the overall EPC contractor to complete the detailed engineering and to construct the planned Pecos County Crude Distillation Unit refinery earlier announced by MMEX. BIL is an industry leader in design, engineering, procurement and construction (EPC) solutions.
MMEX Resources Corp. (MMEX), closed Friday's trading session at $0.0002, up 100.00%, on 95,761,731 volume with 44 trades. The average volume for the last 3 months is 64,129,094 and the stock's 52-week low/high is $0.000000999/$0.237994998.
Lexington Biosciences, Inc. (LXGTF)
Awesome Penny Stocks, Penny Stock Hub, MarketWatch, Morningstar, Interactive Brokers, TradingView, Dividend Investor, Tech Stock Insider, InvestorsHub, Wallet Investor, 4-Traders, and Market News Updates reported earlier on Lexington Biosciences, Inc. (LXGTF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
A medical device company, Lexington Biosciences, Inc. is developing the HeartSentry. This is a new non-invasive diagnostic device to measure and monitor cardiovascular health through assessing the function of a person's vascular endothelium. This is the vital innermost lining of a person's cardiovascular system. The Company’s aim is to become a leader in the development of clinical grade cardiovascular self-measurement solutions for home and clinical use. Lexington Biosciences has offices in Vancouver, British Columbia; and Reno, Nevada.
Lexington is engaged with the US FDA (Food and Drug Administration) and other regulatory agencies on the required product approvals for the HeartSentry. HeartSentry targets the fast-growing self-measurement medical device sector. The design of the HeartSentry unit is to use Bluetooth and Cloud technology to provide up-to-date and accurate readings of an individual’s total cardiovascular health via electronic monitoring for risk-assessment and treatment effectiveness targeting the prevention of heart attack and stroke.
HeartSentry is its flagship, and first device currently advancing to commercial deployment. The HeartSentry core technology underwent development at the University of California Berkeley over a fifteen-year research and development (R&D) period involving many research studies and product iterations resulting in a portfolio of numerous pending and issued patents licensed to Lexington Biosciences.
Lexington Biosciences announced earlier this year the completion of the initial HeartSentry study conducted at San Francisco Bay-area Diablo Clinical Research. Lexington Biosciences’ goal is to make HeartSentry accurate, fast, and cost effective so it can become the standard of care for cardiologists, general practitioners, and ultimately patients for first line evaluation of a person's cardiovascular health.
Over this past summer, Lexington Biosciences completed its first phase of clinical testing at Diablo Clinical Research. The results of the study validated safety protocols, provided Lexington with critical information for product iteration, algorithm development, and clinical testing protocol refinement in preparation for the forthcoming multi-center clinical study series.
Lexington Biosciences, Inc. (LXGTF), closed Friday's trading session at $0.065, up 51.5858%, on 18,030 volume with 10 trades. The average volume for the last 3 months is 5,197 and the stock's 52-week low/high is $0.009999999/$1.29999995.
Maricann Group, Inc. (MRRCF)
Weed Newswire, OTC Markets, Barchart, NewCannabisVentures, Stockhouse, Investopedia, Insider Financial, YCharts, The Street, MarketWatch, 4-Traders, Marketwired, Investors Hub, and TradingView reported on Maricann Group, Inc. (MRRCF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Maricann Group, Inc. produces and distributes marijuana for medical purposes. The Company offers dried marijuana, cannabis oil, and gums. In addition, it provides accessories. These includes vaporizers, grinders, and other paraphernalia. OTCQB-listed, Maricann Group has its head office in Burlington, Ontario, and Munich, Germany. The Company has production facilities in Langton, Ontario.
On September 24, 2018, Maricann Group announced that it intends to change its name to Wayland Group Corp. In the interim, it expects to start operating via its subsidiaries under the business name “Wayland Group”. In expectation of the proposed name change, the Company also announced that, effective September 25, 2018, its ticker symbol on the Canadian Securities Exchange will be “WAYL”.
The Company is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Maricann Group has federal licenses in Canada to cultivate, extract, formulate, and distribute cannabis.
In Langton, Ontario, Maricann operates a medicinal cannabis cultivation, extraction, and formulation and distribution business under federal license from the Government of Canada, and Dresden, Saxony, Germany. The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. At present, the Company is undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) build out, to support existing and future patient growth.
The Company’s Germany-based Ebersbach facility targets the significant European market with 820,000 sq. ft. of cultivation space and greater than 12,000 patients. Maricann has developed educational programming for patients and healthcare professionals. Through exclusive pharmacy agreements with approximately 20 percent of the nation’s pharmacies, Maricann is working to become a leading provider of cannabis at physical point-of-sale locations that patients trust.
One of Maricann Group’s acquisition’s is NanoLeaf Technologies. NanoLeaf is a biotechnology company. It has licensing rights to a number of globally patented technologies that provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.
Additionally, Maricann Group acquired Haxxon AG. The acquisition of Haxxon forms an important element of Maricann’s European expansion strategy. Maricann is now positioned to enter the Swiss market via Haxxon’s production of feminized high CBD cannabis plants.
Recently, Maricann (Wayland Group) announced that it will open its first retail location in Zurich, Switzerland in 2019. It will serve the market with high-quality cannabis products, which contain a maximum THC content of 1 percent. The opportunity comes on the heels of the Company’s strategic acquisition of Haxxon AG, granting Maricann (Wayland) the opportunity to take advantage of Haxxon’s production facilities in Regensdorf, Switzerland, and its production of feminized high CBD cannabis plants.
Maricann (Wayland Group) also recently announced that it entered into an agreement to supply Cannamedical Pharma GmbH, a licensed, privately owned importer and distributor of cannabis in Germany to more than 2,200 pharmacies, with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three year term. The two companies have completed mandatory quality assurance and control audits. They have scheduled the first shipment in December of this year.
Maricann Group, Inc. (MRRCF), closed Friday's trading session at $0.0083, up 76.5957%, on 204,900 volume with 21 trades. The average volume for the last 3 months is 400,228 and the stock's 52-week low/high is $0.000099999/$1.25.
Purebase Corp. (PUBC)
InvestorsHub, MarketWatch, 4-Traders, OTC Markets, and Stockhouse reported previously on Purebase Corp. (PUBC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Purebase Corp. centers on delivering high quality organic mineral products for the agricultural sector. A diversified, natural, and industrial mineral resource enterprise, the Company concentrates on the acquisition, development, mining, and marketing of industrial and natural mineral properties in California, Nevada, and the rest of the U.S. as its chief priority. Purebase has its headquarters in Ione, California and the Company’s shares trade on the OTC Markets’ OTCQB.
Purebase has created Purebase Networks. This is an AgTech startup. Purebase Networks concentrates on combining Internet of Things (IoT) agricultural sensors, wireless networking, and also cloud technologies to deliver the industry's first vertically integrated agricultural supply chain.
Purebase Networks will partner with Purebase Corp. to deliver proprietary, organic soil amendments for farmers. Purebase Networks will also provide farmers with access to Purebase Networks' proprietary "Big Data" analytics. This is to provide more visibility into crop and soil performance.
Pertaining to the agriculture industry, Purebase provides soil amendment and fertilizer solutions, which are of major benefit to large commercial farming operations and retail consumer markets. Purebase Grow is a total family of soil amendment products.
Grow products include Purebase Humate Advantage; Purebase Potassium & Sulfate Advantage; Purebase Soil Advantage; Purebase Shade Advantage; and Purebase Fulvic Advantage. The focus of these products is to provide a better, more natural way to grow, manage, and increase yield on the farm and deliver higher quality products to consumers’ tables.
Concerning the construction industry, Purebase provides a Supplementary Cementitious Material (SCM). This is an additive that may be used in cement for large infrastructure construction projects for government, commercial, and residential buildings. Purebase Build SCM appreciably lessens greenhouse gas emissions and harmful particulate matter. Moreover, it reduces the overall cost of concrete. This is while increasing its strength.
Regarding its facilities and properties, the Company’s focus is on the commercialization of its three green mining properties. It owns two pozzolan projects, one in Northern California, and the other in Southern California. These serve the regions’ primary markets for the agricultural and construction sectors. Purebase’s potassium-sulfur project is in south-central Nevada near the Company’s central valley agricultural market.
Purebase Corp. (PUBC), closed Friday's trading session at $0.30, up 46.3415%, on 336 volume with 1 trade. The average volume for the last 3 months is 14,609 and the stock's 52-week low/high is $0.020999999/$0.990000009.
The QualityStocks Company Corner
- Green Hygienics Holdings Inc. (OTCQB: GRYN)
- ChineseInvestors.com (CIIX)
- Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
- No Borders Inc. (OTC: NBDR)
- SinglePoint, Inc. (SING)
- HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)
- SRAX Inc. (NASDAQ: SRAX)
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF)
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
- Genprex Inc. (NASDAQ: GNPX)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
- Sharing Services Global Corporation (SHRG)
- LiveWire Ergogenics Inc. (OTC: LVVV)
- Pressure BioSciences Inc. (PBIO)
Green Hygienics Holdings Inc. (OTC: GRYN)
Green Hygienics Holdings Inc. (OTCQB: GRYN) was featured today in a publication from HempWireNews, examining how the 2018 Farm Bill was instrumental in pushing the hemp industry from restriction to one worth billions of dollars. The legislation legalized the cultivation and sale of industrial hemp, classifying hemp as cannabis with less than 0.3% THC content. On condition that farmers grew the crop under state and tribal programs, and they adhered to the rule on THC (delta-9 tetrahydrocannabinol), they were free to farm hemp.
Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD). With more than 25 years of experience in agricultural science and innovation, Green Hygienics aims to become one of the largest providers of industrial hemp-derived CBD products on the planet.
Green Hygienics’ business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable intellectual property (IP) and growing rapidly through strategic acquisitions. With direct regard to acquisitions, the company acts as a business accelerator and a vertical integrator supporting rapid growth and development of companies with extraordinary potential.
Innovation – the Future of Commercial Cultivation
The greatest challenge of the cannabis industry is determining how to deliver a safe and premium-quality product on a consistent basis; antiquated production methods are riddled with recalls and are unsafe from a cultivation production standpoint. Green Hygienics’ solution is to employ scientific methodology combined with sustainable farm practices to achieve optimal soil refinement. The company’s objectives are to produce higher yields and a superior product on a consistent basis to always remain compliant through diligent testing. A secure, premium-quality supply chain is the foundation for the company’s operations.
Green Hygienics’ cultivation approach is based on scientific measurements and data analysis, which transform the cultivation environment into a laboratory environment to deliver superior product.
Processing hemp to produce the finest-quality CBD is a complex, multistage process that should be performed with adherence to the highest standards. Once harvested, the hemp must be carefully handled, dried and stored to prepare it for CBD extraction. Each and every step must be given full care and attention. Green Hygienics’ ambition is to create state-of-the-art infrastructure, employ the latest large-scale processing technologies and adhere to strict quality management systems.
The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.
Brand Development, Marketing and Direct Sales
One of the core drivers of the Green Hygienics business model is to develop or acquire unique brands with global distribution potential. The company sees the market becoming increasingly competitive, and establishing Green Hygienics’ own distinct, trusted brands will be important. By controlling its own supply chain, the company can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. Successful branding is demonstrated by a positive response to a company’s customer service, reputation and products, and Green Hygienics Holdings is acutely aware of the value in this.
Ahead of the Curve
The clear competitive advantage Green Hygienics holds over industry peers is cultivating premium product within the upper-scale product category more efficiently than anyone else in the industry. Currently, the average-size hemp farm in North America is 9 acres. Green Hygienics addresses the challenge of scalability through its farming methodology.
The company’s objective is to produce a higher quality of product at a lower cost and to deliver the finest-quality product to consumers without exception.
In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. The premium cannabis market will continue to achieve higher pricing, and the demand will stabilize. At the end of the day, successful branding backed by superior product will cause companies like Green Hygienics to rise above the competition.
Companies within the cannabis sector, states and lawmakers are still figuring out how legislation, consumer demand and innovations will shape the industry. As a safeguard and for long-term resilience, Green Hygienics is preparing for the next plateau with proprietary cultivation and processing systems and tightly controlled growth environments that enable containment of production costs, delivery of higher yields and production of a premium product. These margins will provide the company with a strategic advantage within an increasingly competitive marketplace.
Green Hygienics is constantly studying the market dynamics in North America and abroad and anticipates that both the domestic and international markets will appreciate and be willing to pay a premium to those companies that can deliver best-in-class products.
In line with this expectation, the company’s additional objectives are to secure investment, enhance its balance sheet and increase its value through profitable operations as well as through acquiring and owning the real estate or land it builds upon. Over the long term, this will help Green Hygienics grow in value, provide leverage for rapid expansion and offer security for investors. The company will be positioned to capitalize on any opportunity within the industry or to acquire distressed assets, which is part of its growth strategy.
Green Hygienics plans to establish lead brands starting in the California market, to secure trademarks, and to develop and secure intellectual property assets with regard to cultivation and processing.
Green Hygienics Holdings Inc. (GRYN), closed Friday's trading session at $2.00, up 1.0101%, on 1,050 volume with 4 trades. The average volume for the last 3 months is 9,722 and the stock's 52-week low/high is $0.224999994/$2.48000001.
- 5 Problems Farmers Identify in the USDA Hemp Rules
- Green Hygienics Holdings Inc. (GRYN) Appoints Sid Senroy to Head Quality Control in Recognition of Critical Industry Need for Compliance
- Producers Turn to Congress and State Regulators for Help in Convincing the USDA to Change Hemp Rules
ChineseInvestors.com (CIIX) was featured today in a publication from CBDWire, examining how Oren Levy, a New York-based CBD retailer, finally got back a shipment of hemp seized by the New York Police Department (NYPD). Ronen Levy, his brother, was arrested after the police intercepted the shipment, mistaking it for illegal marijuana, and slapped with felony marijuana trafficking charges.
Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.
Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.
At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.
CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.
The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.
Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.
In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.
ChineseInvestors.com (CIIX), closed Friday's trading session at $0.18, up 9.1074%, on 30,944 volume with 21 trades. The average volume for the last 3 months is 51,895 and the stock's 52-week low/high is $0.150000005/$0.550000011.
- Brooklyn CBD Retailer Gets Back Hemp Seized by NYPD
- ChineseInvestors.com Inc. (CIIX) Leveraging Diversified Revenue Streams
- ChineseInvestors.com Inc. (CIIX) Establishing Position as Leader in China’s Budding CBD Industry
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)
Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF), a producer of high-quality feature films and episodic television with international appeal, is well positioned to capitalize on the growing consumer demand for entertainment content. To view the full article, visit http://nnw.fm/6Dnb4.
Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.
Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.
Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.
The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.
Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.
Management Team with Proven Track Records
Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.
Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.
Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.
Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.
Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.
17-Title Movie Slate — Greenlit
Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.
Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.
The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.
Potential for Breakout Success
Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.
Note: Potential breakout films are not factored into company’s revenue projections.
Base Hits and Home Runs
In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.
Recent Industry Breakout Films Include:
- SAW – $1.2 million budget = $103.9 million in sales
- Pulp Fiction – $8 million budget = $212 million in sales
- My Big Fat Greek Wedding – $5 million budget = $250 million in sales
- Lost in Translation – $4 million budget = $120 million in sales
- Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)
Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.
Recent Wonderfilm Releases
- Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
- Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
- Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
- Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.
Wonderfilm Global Distribution
At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.
Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.
The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.
A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.
Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.
Wonderfilm Business Model
Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.
Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.
Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.
Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.
Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.
Sales overages once contracted presale threshold is surpassed.
The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.
Note: The nature of the film business is that box office revenue lags production up to a couple of years.
$50 Million Wonderfilm Production Fund (WPF):
Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.
The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.
For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.
All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.
Wonderfilm Media Corporation (OTC: WDRFF), closed Friday's trading session at $0.12, up 48.1481%, on 63,690 volume with 11 trades. The average volume for the last 3 months is 60,051 and the stock's 52-week low/high is $0.072099998/$0.452270001.
- Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Capitalizing on Growing Demand for High-Quality Content
- Wonderfilm Media Corporation Update: Cease Trade Order Due to Late Filing of Financial Statements
- Wonderfilm Media Corp. (TSX.V: WNDR) (OTCQB: WDRFF) Employs Lean Production Business Model
No Borders Inc. (OTC: NBDR)
No Borders Inc. (OTC: NBDR) has executed a distribution and direct supply agreement with KB Dental of South Korea for the latter’s line of specialty dental and endodontic products, including the brands Kerator, MCT Bio and Maruchi. Under the agreement, KB Dental will supply No Borders’ subsidiary No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies, with a diverse product line ranging from Endosonic systems to EndosealMTA pastes. These high-value specialty products are in high demand by endodontic offices across the U.S.
No Borders Inc. (OTCQB: NBDR) specializes in the acquisition, creation and scaling of commercial products by utilizing cutting-edge technologies designed to reduce costs while increasing revenues and shareholder value. With active subsidiaries in healthcare, education, cannabidiol (CBD), finance and technology, No Borders is uniquely positioned to use its expertise to improve margins and add business lines within target verticals. No Borders is headquartered in Arizona with remote work resources in the U.S., South America, Asia and Europe.
Different by Design
Deeply experienced at actionable data compilation, analysis and utilization, No Borders believes that data utilization in a Web 3 ecosystem of predictive analytics, blockchains, consensus algorithms, IoT and 5G are vital keys to the future of disrupting global business.
The company leverages its technological talent and visionary approach alongside best-in-class branding, messaging and product teams to simultaneously deploy multiple vertical product offerings at the same time.
With resources around the world, No Borders operates as a 100% remote work, lean operating organization with a founding ideological focus on “Lifestyle by Design.” No Borders’ teams are built by allowing people to work when they want and from where they want as long as deliverables and results are achieved. This structure allows for strategic talent acquisition without the need for relocation or commuting; lowered operating and fixed costs; as well as improved morale and substantially increased staff productivity.
- No Borders Dental Resources Inc. provides equipment and supplies to medical and dental professionals across the U.S. through the trade name, MediDent Supplies. MediDent has a strategic focus on expanding product portfolios and optimizing lifetime customer value while minimizing customer acquisition cost in the medical, dental and veterinary spaces.
- No Borders Naturals is a purveyor of health and wellness products for active consumers and their pets. No Borders Naturals aims to be an industry leader in alternative wellness product offerings and is currently expanding its digital offering with impactful product up-sell opportunities such as a series of “Buy Two-Get One” on products on its 1000mg CBD tincture, collagen and retinol beauty cream.
- No Borders Labs Inc. provides leading-edge tech tools to the No Borders family of companies along with building, testing and deploying technology solutions and products to the market while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency.
- No Borders Funding Inc. provides internal capital and strategic funding options for the family of No Borders companies while actively engaging and networking to find, acquire, structure and deploy unique financial products, solutions and systems with traditional, distributed ledger and blockchain technologies.
- No Borders Education Inc. provides internal staff training and strategic education tools for the No Borders family of companies while pursuing external revenue generating educational opportunities within the verticals for which No Borders deploys products, services or technologies.
No Borders CEO Joseph Snyder is a serial entrepreneur whose experiences in real estate investment, financial services and digital strategy over the last 15 years provide a strong, grounded foundation for the structure and ideas outlined in the company’s strategic plan. He brings a unique set of long-term business experiences that provide No Borders with a clear “mile-high” view of the intricately linked systems and challenges associated with growing and scaling our vision.
COO Cynthia Tanabe, a licensed real estate agent/broker since 2004, has successfully built a highly respected investor and bank-focused real estate and property management firm in Arizona with tens of millions of dollars of properties owned and sold.
CTO Chris Brown has 14 years of experience in the IT industry ranging from full stack programming, hardware support, engineering and maintenance, to enterprise-level information system analysis, design, development and implementation. From his background in Air Force intelligence to earning dual B.S. degrees in computational mathematics and biochemistry from Arizona State University, Brown has been engrossed with technologies such as artificial intelligence, machine learning, and decentralized blockchain ledger systems and their connections with real world business applications.
Management is backed by an advisory board with a diverse range of expertise blockchain, brand development, specialty retail, branded consumer products, technology, marketing and other specialties pertinent to No Borders’ growth strategy.
No Borders Inc. (NBDR), closed Friday's trading session at $0.01488, up 9.4118%, on 11,000 volume with 2 trades. The average volume for the last 3 months is 64,545 and the stock's 52-week low/high is $0.007699999/$0.048799999.
- No Borders Inc. (NBDR) Receives U.S. Distribution Rights for High-Value, Specialty Dental and Endodontic Products
- No Borders Inc. (NBDR) Leveraging Blockchain Expertise to Enhance CBD Product Reliability
- What You Need to Know About CBD Patches
SinglePoint, Inc. (SING)
SinglePoint, Inc. (SING) was highlighted in today's edition of the Cleantech and Climate Change Podcast, talking about today's problems and solutions for the future. Listen to the Podcast: http://ibn.fm/yydjO.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Friday's trading session at $0.00785, up 1.9481%, on 4,363,356 volume with 142 trades. The average volume for the last 3 months is 3,000,290 and the stock's 52-week low/high is $0.007/$0.028799999.
- Cleantech and Climate Change Podcast: Ringing in Green for 2020
- 7 Predictions for the Hemp Industry in 2020
- SinglePoint: SchollyME Joins REALRUN to Showcase the Best Upcoming California Basketball Players - Other Sponsors Include Nike, 7/11, Uptime Energy Drink, Direct Solar of America and More!
HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)
HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) was featured today in a publication from CBDWire, examining how HTPRF is approaching its end of year operations riding high on a series of strategic decisions designed to establish a modular, economical production chain for obtaining hemp, extracting profitable chemical compounds and distributing those compounds through sales-to-consumer marketplaces. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. A wave of marijuana legalization has been sweeping across the U.S., and its genesis can be traced to Colorado and Washington approving marijuana legalization initiatives way back in 2012. In each biennial election that followed, additional states followed through with their own marijuana legalization initiatives, and experts believe 2020 will be a landmark year for marijuana.
HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.
Advanced Extraction Technologies
For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:
- LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
- PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
- Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.
Delta Purification® Technology
HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:
- Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
- Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
- Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.
Hemp Biomass and Tolling Contracts
HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.
Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.
Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.
The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.
Sales and Offtake Agreements
HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.
HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.
Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.
Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.
HTC Extraction Systems (OTCQB: HTPRF), closed Friday's trading session at $0.1787, even for the day, on 300 volume. The average volume for the last 3 months is 3,260 and the stock's 52-week low/high is $0.100299999/$0.920000016.
- HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Wraps Up Productive Year in Cannabinoid Refining Operation
- 420 with CNW – 6 States That Could Vote on Marijuana Ballot Measures in 2020
- Nebraska Submits its Hemp Plan to the USDA
SRAX Inc. (NASDAQ: SRAX)
Digital-marketing and consumer-data-management technology company SRAX (NASDAQ: SRAX) provides consumers the power to own their data and obtain payment for the release of that date. To view the full article, visit http://nnw.fm/AnB9c.
SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.
Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.
SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.
- SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
- SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
- SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
- SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
- SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
- SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.
BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.
The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.
Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.
Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.
SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.
BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.
The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.
SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.
BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.
Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.
Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.
SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $2.20, off by 12.3506%, on 89,841 volume with 560 trades. The average volume for the last 3 months is 130,707 and the stock's 52-week low/high is $1.04999995/$5.8499999.
- SRAX Inc. (NASDAQ: SRAX) Offers Consumers Power to Own Their Data
- SRAX, Inc. (NASDAQ: SRAX) Extends Expiration Time for BIGtoken Special Dividend through December 31, 2020
- SRAX Inc. (NASDAQ: SRAX) Favorably Positioned for Growth in Q4
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)
Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) was featured today in a publication from HempWireNews, examining how THC Testing itself has been an issue. According to Virginia-based Susan Corbett, farmers cannot predict exactly how different cultivars will react in different environments, soils, and climates. Restricting the growth to 0.3% THC will severely hurt the market, she says. “We believe the limit should be 1% THC. This will allow farmers to produce high-quality CBD flowers that will bring a decent profit while maintaining a non-psychoactive outcome.”
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (CNPOF), closed Friday's trading session at $0.96425, off by 2.8904%, on 58,629 volume with 120 trades. The average volume for the last 3 months is 140,936 and the stock's 52-week low/high is $0.779999971/$4.7800002.
- 5 Problems Farmers Identify in the USDA Hemp Rules
- CBD Bar Set to Be Opened in Manchester
- Lawmakers Write Multiple Letters Asking the USDA to Modify Hemp Rules
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)
The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) was featured today in a publication from CBDWire, examining how Oren Levy, a New York-based CBD retailer, finally got back a shipment of hemp seized by the New York Police Department (NYPD). Ronen Levy, his brother, was arrested after the police intercepted the shipment, mistaking it for illegal marijuana, and slapped with felony marijuana trafficking charges. After his arrest, Ronen Levy was charged with felony marijuana trafficking charges. He had been picking up the shipment on behalf of his brother, who was recovering from a recent surgery. Also today, CannabisNewsWire released a report on the company detailing how SPRWF recently announced the appointment of three experienced operations professionals to the company’s executive team. To view the full article, visit http://cnw.fm/MMS7g
Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.
Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.
A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.
Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.
In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:
- Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
- Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
- Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
- Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.
Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:
- Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
- Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
- Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
- R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.
Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.
Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.483, off by 2.0284%, on 263,465 volume with 194 trades. The average volume for the last 3 months is 502,136 and the stock's 52-week low/high is $0.432000011/$1.7888.
- Brooklyn CBD Retailer Gets Back Hemp Seized by NYPD
- Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Strengthens Team through Key Operational Hires
- Marijuana Stocks To Watch: Last Trade of 2019
Genprex Inc. (NASDAQ: GNPX)
Genprex Inc. (NASDAQ: GNPX) was highlighted today in a publication from Channelchek, examining how gene therapy is a biological product that mediates its effect by transcription and/or translation of transferred genetic material by integrating into the host genome. It is administered as nucleic acids, viruses, or genetically engineered microorganisms. In gene therapy, a normal gene is inserted into the genome, often via a viral vector, to replace an abnormal gene responsible for causing a certain disease.
Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.
Research and Development
Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.
Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.
Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.
Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.
TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.
Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.
Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.
Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.
Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.
Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.
Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.
Genprex Inc. (NASDAQ: GNPX), closed Friday's trading session at $0.2811, off by 9.381%, on 675,079 volume with 833 trades. The average volume for the last 3 months is 504,196 and the stock's 52-week low/high is $0.231000006/$2.25999999.
- New Era of Gene Therapy
- Genprex Announces $1.26 Million Registered Direct Offering
- 4 Penny Stocks To Buy For Under $2.50 Right Now
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) was featured today in the 420 with CNW by CannabisNewsWire. A wave of marijuana legalization has been sweeping across the U.S., and its genesis can be traced to Colorado and Washington approving marijuana legalization initiatives way back in 2012. In each biennial election that followed, additional states followed through with their own marijuana legalization initiatives, and experts believe 2020 will be a landmark year for marijuana.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed Friday's trading session at $0.158, off by 2.4089%, on 38,520 volume with 36 trades. The average volume for the last 3 months is 137,376 and the stock's 52-week low/high is $0.139899998/$0.930000007.
- 420 with CNW – 6 States That Could Vote on Marijuana Ballot Measures in 2020
- 420 with CNW – Chicago Mayor Wants Marijuana Consumption Allowed in Some Public Places
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Reveals Cannabis 2.0 Products
Sharing Services Global Corporation (SHRG)
Sharing Services Global Corporation’s (OTCQB: SHRG) Elepreneurs LLC subsidiary and its independent sales contractors — called Elepreneurs — have implemented the interactive, video-based VERB sales-marketing app platform developed by Verb Technology Company Inc. Originally used by Elepreneurs in the United States, VERB will soon be unveiled in Canada (http://nnw.fm/cB01C). To view the full article, visit http://nnw.fm/qfLB4.
Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.10, off by 2.9126%, on 115,234 volume with 15 trades. The average volume for the last 3 months is 28,719 and the stock's 52-week low/high is $0.065800003/$0.3944.
- Sharing Services Global Corporation (SHRG) Subsidiary Adopts Interactive, Video-Based VERB Platform
- Sharing Services Global Corporation (SHRG) Achieves Record Q2 Revenues, Cumulative Sales of $169 Million
- Sharing Services Global Corp. (SHRG) Subsidiary’s Independent Sales Force Utilizes Video-Based Platform
LiveWire Ergogenics Inc. (OTC: LVVV)
LiveWire Ergogenics (OTC: LVVV) expects to perform well during 2020 as industry analysts project the market for cannabis products will increase to $80 billion over the next decade, according to a recent AP article (http://cnw.fm/r01nN). To view the full article, visit http://cnw.fm/sbY1G.
LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.
During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:
PODs and Distribution in Coachella, California
For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.
Estrella Ranch in Paso Robles, California
Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.
The Paso Robles Nursery
LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.
LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.
GHC Ventures Subsidiary
GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.
GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.
LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.
LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.
7X Pure™ Dosing and Verification System
LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.
The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.
The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.
Acquisitions & Operations
To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.
Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.
The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.
LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.
LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.
Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.
As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.
Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.
Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.
Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.
Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.
Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.
LiveWire Ergogenics Inc. (OTC: LVVV), closed Friday's trading session at $0.0068, off by 1.4493%, on 571,416 volume with 28 trades. The average volume for the last 3 months is 1,157,152 and the stock's 52-week low/high is $0.0035/$0.037.
- LiveWire Ergogenics Inc. (OTC: LVVV) Sees Optimistic Future as Cannabis Products Market Forecasted to Reach $80 Billion by 2030
- Nebraska Submits its Hemp Plan to the USDA
- How Much CBD Oil Does Your Body Actually Absorb?
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $1.013, up 6.6316%, on 5,173 volume with 13 trades. The average volume for the last 3 months is 12,523 and the stock's 52-week low/high is $0.600600004/$4.0300002.
- Zacks Maintains Strong $4.44 Price Target for Pressure BioSciences Inc. (PBIO)
- Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc.
- Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q3 2019 Financial Results, Provide Business Update
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- B2Digital Inc. (BTDG) Secures Fully Reporting Status with SEC
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Non-Binding LOI to Acquire Controlling Equity Interest in Fuzhou Csfctech Co., Ltd.
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) 420 with CNW – Top Italian Court Rules That Growing a Few Marijuana Plants at Home is Legal
- Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) CBD Bar Set to Be Opened in Manchester
- ChineseInvestors.com (CIIX) Leveraging Diversified Revenue Streams
- City View Green (CSE: CVGR) (OTC: CVGRF) Completes First Tranche Closing of Private Placement
- CloudCommerce (OTCQB: CLWD) SEC Qualifies CloudCommerce Reg A+ Public Offering
- Dama Financial - Product Integration With PayWana Set to Revolutionize Retail Checkout Processing
- Endonovo Therapeutics (OTCQB: ENDV) Provides SofPulse® To All NFL Teams
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Selects Cognata as Simulation Partner for Camera Vision Systems
- Genprex, Inc. (NASDAQ: GNPX) New Era of Gene Therapy
- GP Solutions (GWPD) GrowPods May Help Reduce Foodborne Illnesses
- Grapefruit Boulevard Investments Inc. (IGNG) 420 with CNW – A Primer on Medical Marijuana Products and Dosage Tips
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) 420 with CNW – West Virginia Warms Up to Medical Marijuana
- Green Hygienics Holdings Inc. (OTC: GRYN) Appoints Sid Senroy to Head Quality Control in Recognition of Critical Industry Need for Compliance
- Hemptown USA - Unveils New CBG-Based Product Line at MJBizCon 2019; Reports 2019 Harvest Results
- HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Nebraska Submits its Hemp Plan to the USDA
- InsuraGuest Inc. - Poised to Exploit Booming European, Asian Hotel Markets through Planned Expansion
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) (FRA: IB3) Cincinnati Nurse Debuts CBD Product Line
- Jerrick Media Holdings, Inc. (JMDA) CEO Details 2019 Successes and Forward Strategy in Weekly Update
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) 420 with CNW – It’s Official, South Dakota Will Vote on Medical Marijuana Measure in 2020
- LiveWire Ergogenics Inc. (OTC: LVVV) Nebraska Submits its Hemp Plan to the USDA
- Marijuana Company of America Inc. (MCOA) 7 Predictions for the Hemp Industry in 2020
- MCTC Holdings Inc. (MCTC) Files Fifth Patent Under Hemp You Can Feel Brand
- Neutra Corp. (OTCQB: NTRR) Colorado Department of Agriculture Approves Four Additional Hemp Varieties
- No Borders Inc. (OTC: NBDR) Leveraging Blockchain Expertise to Enhance CBD Product Reliability
- Nightfood, Inc. (OTCQB: NGTF) CEO Sean Folkson Interviewed by Wall Street Reporter -- Discusses Recent Research on the $50 Billion+ Night Snacking Market
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) Ships First Wave of Vaporizer Offerings
- ORHub Inc. (ORHB) Announces Changes to Board of Directors, Management
- OriginClear (OCLN) Case Study Fully Validates Technology; Solves Barrier to Growth for Animal Farmers
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Reports Unaudited 2019 Third Quarter Results
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Announces Results of AGM and Expands Board of Directors
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Everything You Ever Wanted to Know About the Pet Cannabidiol Market
- Predictive Oncology Inc. (NASDAQ: POAI) Building AI-driven Ovarian Cancer Model to Predict Tumor Drug Response, Patient Outcome
- Pressure BioSciences Inc. (PBIO) Zacks Maintains Strong $4.44 Price Target
- Quest Patent Research Corp. (QPRC) Court Denies Transfer Motion in Quest Patent Research Corp. (QPRC) Subsidiary’s Patent Litigation against Apple
- Sharing Services Global Corporation (SHRG) Achieves Record Q2 Revenues, Cumulative Sales of $169 Million
- Sigma Labs, Inc. (NASDAQ: SGLB) Transforming the Blossoming 3D-Printing Sector with Groundbreaking Quality-Assurance Software
- SinglePoint, Inc. (SING) SchollyME Joins REALRUN to Showcase the Best Upcoming California Basketball Players - Other Sponsors Include Nike, 7/11, Uptime Energy Drink, Direct Solar of America and More!
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Closes Private Placement of CDN$7,866,000 in Unsecured Convertible Debentures
- Spectrum Global Solutions, Inc. (SGSI) Q3 2019 Financial Report Reveals Stronger Balance Sheet, Larger Portfolio
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Top Italian Court Rules That Growing a Few Marijuana Plants at Home is Legal
- SRAX Inc. (NASDAQ: SRAX) Extends Expiration Time for BIGtoken Special Dividend through December 31, 2020
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Entering Commissioning Phase of its First-of-a-Kind Direct Lithium Extraction Demonstration Plant
- Sugarmade, Inc. (SGMD) Colorado Department of Agriculture Approves Four Additional Hemp Varieties
- The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Marijuana Stocks To Watch: Last Trade of 2019
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Cincinnati Nurse Debuts CBD Product Line
- Trxade Group Inc. (TRXD) Reports Consistent Revenue Growth Trend, Plans to Expand Service Offering
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Chicago Mayor Wants Marijuana Consumption Allowed in Some Public Places
- VPR Brands, LP (VPRB) US Hemp Farmers Join Forces and Launch National Association
- Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) College Student Creates CBD Gumballs
- Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) Update: Cease Trade Order Due to Late Filing of Financial Statements
- Xalles Holdings Inc. (XALL) Partners with Automated Cryptocurrency Trading Engine to Enable Fast, Efficient Trading
- Youngevity International, Inc. (NASDAQ: YGYI) Set to Ring Nasdaq Closing Bell on January 7 in Celebration of Fit Week 2020
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.